Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis

BACKGROUND: The efficacy and safety of rituximab (RTX) in adult frequent-relapsing (FR) or steroid-dependent (SD) nephrotic syndrome (NS), including minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS), are still inconclusive. METHODS: We performed a systematic review and meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Cheng, Yang, Bo, Xu, Jing, Zhou, Chenchen, Zhang, Liming, Gao, Xiang, Dai, Bing, Yu, Shengqiang, Mao, Zhiguo, Mei, Changlin, Xu, Chenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
CKJ Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173623/
https://www.ncbi.nlm.nih.gov/pubmed/34094516
http://dx.doi.org/10.1093/ckj/sfaa191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173623/
https://www.ncbi.nlm.nih.gov/pubmed/34094516
http://dx.doi.org/10.1093/ckj/sfaa191

Ejemplares similares